Skip to main content
Glama

Arcgis Peterborough

by io.github.pipeworx-io

Resolve Entity

resolve_entity
Read-onlyIdempotent

"What's the ticker for…" / "find the CIK for…" / "what's the LEI for…" / "what's the RxCUI for…" / "look up the ID for…" / "what is X's official identifier" / "who owns X" / "is X a subsidiary of Y" — resolve a user-spoken NAME to the canonical/official identifiers other tools require as input. Use FIRST whenever you have a name but need an ID. SUPPORTED TYPES: "company" (cross-source identity spine: 10-digit CIK + ticker + company_name from SEC EDGAR, legal-entity LEI from GLEIF with parent/ultimate-parent/children ownership when the LEI resolves, and security FIGI from OpenFIGI — by exact ticker map when a ticker is implied, and otherwise by name search, so NON-EQUITY instruments that never have a ticker (municipal and corporate bonds, notes, authority debt) DO resolve here; when a name matches more than one instrument it asserts nothing and returns figi_candidates to pick from, which is the correct answer to an issuer name that does not identify a single bond; every identifier is labelled with the source that established it, and an identifier that could NOT be resolved is stated explicitly under unresolved rather than omitted — accepts ticker, CIK, ISIN, or company name as input; an ISIN like "CH0038863350" resolves to the LEGAL ENTITY that issued the security via the GLEIF ISIN-to-LEI mapping, covering non-US issuers EDGAR cannot reach), "drug" (returns RxCUI + ingredient + brand from RxNorm + pipeworx://rxnorm/concept/{rxcui} citation; accepts brand or generic name). LEI/FIGI enrichment degrades gracefully — if GLEIF or OpenFIGI is unavailable, the EDGAR identifiers still return. Each call cascades through several lookup endpoints internally — using resolve_entity replaces 2-3 manual lookups.

Input Schema

TableJSON Schema
NameRequiredDescriptionDefault
typeYesEntity type: "company" or "drug".
valueYesFor company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., "ozempic", "metformin"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed ("NEW YORK ST DORM AUTH"), never the question's full noun phrase ("NEW YORK ST DORM AUTH revenue bonds"): the FIGI lookup matches instrument names, so trailing security-class words match nothing.

Schema Changelog

Changes observed during successful MCP inspections. Dates show when Glama detected each change.

  1. Changed1 schema field changed
    • changedInput schema / properties / value / description
      Previous value: -"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\")."New value: +"For company: ticker (AAPL), CIK (0000320193), or name. For drug: brand or generic name (e.g., \"ozempic\", \"metformin\"). Pass the ENTITY NAME ONLY — for a bond that is the ISSUER exactly as printed (\"NEW YORK ST DORM AUTH\"), never the question's full noun phrase (\"NEW YORK ST DORM AUTH revenue bonds\"): the FIGI lookup matches instrument names, so trailing security-class words match nothing."
  2. First observed

TDQS

A4.7/5.0
Behavior5/5

Does the description disclose side effects, auth requirements, rate limits, or destructive behavior?

Beyond the readOnly/idempotent annotations, the description discloses rich behavioral details: it cascades through multiple lookup endpoints, returns figi_candidates when a name matches multiple instruments, explicitly lists unresolvable identifiers under `unresolved`, and degrades gracefully if GLEIF or OpenFIGI are unavailable. No contradiction with annotations is present.

Agents need to know what a tool does to the world before calling it. Descriptions should go beyond structured annotations to explain consequences.

Conciseness4/5

Is the description appropriately sized, front-loaded, and free of redundancy?

The description is long and dense, but it is front-loaded with examples and a clear 'Use FIRST' directive, and the complexity of the tool justifies the detail. A few parenthetical asides could be tightened, but no sentence is purely filler.

Shorter descriptions cost fewer tokens and are easier for agents to parse. Every sentence should earn its place.

Completeness5/5

Given the tool's complexity, does the description cover enough for an agent to succeed on first attempt?

With no output schema, the description carries the burden of explaining what the agent can expect, and it does: for company it lists CIK, ticker, company_name, LEI ownership data, and FIGI; for drug it lists RxCUI, ingredient, and brand. It also covers ambiguity handling, unresolved identifiers, and failure degradation, making it complete enough to invoke correctly.

Complex tools with many parameters or behaviors need more documentation. Simple tools need less. This dimension scales expectations accordingly.

Parameters5/5

Does the description clarify parameter syntax, constraints, interactions, or defaults beyond what the schema provides?

Though the schema already covers 100% of parameters, the description adds substantial meaning: realistic ticker/CIK/ISIN/name examples, the bond-specific warning to pass only the issuer name, and the distinction between entity types. This is far beyond the schema's basic descriptions.

Input schemas describe structure but not intent. Descriptions should explain non-obvious parameter relationships and valid value ranges.

Purpose5/5

Does the description clearly state what the tool does and how it differs from similar tools?

The description opens with concrete user phrasings ('What's the ticker for…' / 'find the CIK for…') and states a specific verb-plus-resource: resolve a user-spoken NAME to canonical identifiers. It clearly differentiates from siblings like entity_profile and compare_entities by specifying it returns the IDs other tools require, not profiles or comparisons.

Agents choose between tools based on descriptions. A clear purpose with a specific verb and resource helps agents select the right tool.

Usage Guidelines4/5

Does the description explain when to use this tool, when not to, or what alternatives exist?

It explicitly says 'Use FIRST whenever you have a name but need an ID' and details accepted input formats and supported types for company and drug. It does not explicitly name alternatives or say when not to use it, so it misses the full 'when-not/alternatives' criterion.

Agents often have multiple tools that could apply. Explicit usage guidance like "use X instead of Y when Z" prevents misuse.

All Arcgis Peterborough toolsInspect
Try in Browser
RayrunBuild, deploy, and operate MCP servers without becoming an infrastructure team.ray.runAd

Glama MCP Gateway

Add one secure layer between your agents and this server.

TDQS

A3.6/5.0
Disambiguation2/5

Multiple tool families overlap heavily: ask_pipeworx, ask_pipeworx_beta, ask_pipeworx_grounded, deep_research, and validate_claim all route questions to the same underlying 5,767 tools with significant functional overlap. Polymarket tools (polymarket_arbitrage, polymarket_edges, polymarket_edge_tracker, polymarket_fill_risk) also have blurred boundaries around edge detection and fill risk. The ArcGIS tools (search_datasets, layer_info, query_layer) are distinct, but the non-ArcGIS tools dominate and create confusion.

Naming Consistency2/5

The naming conventions are inconsistent across the set. Some tools use verb_noun (ask_pipeworx, query_layer, search_datasets, list_subscriptions), some use bare verbs (forget, recall, subscribe, unsubscribe), and others use descriptive multi-word names (polymarket_fill_risk, scan_competitor_ai_presence, generate_llms_txt). The ask_pipeworx family and polymarket_* family are internally consistent, but the overall set mixes styles without a clear pattern.

Tool Count2/5

34 tools is heavy for a server that appears to be an ArcGIS data server but includes a massive Pipeworx data-research and prediction-market subsystem. The ArcGIS portion only has 3 tools (search_datasets, layer_info, query_layer), while the rest form a separate general-purpose research/betting toolkit. The count feels bloated and unfocused relative to the server's stated name.

Completeness2/5

The ArcGIS surface is incomplete: search_datasets, layer_info, and query_layer offer no update/create/delete or metadata exploration beyond one layer at a time. The Pipeworx portion is broad but lacks clear lifecycle coverage for subscriptions (create/cancel works, but no update), and the memory tools (remember/recall/forget) are peripheral. The set feels like an accidental aggregation of unrelated domains rather than a complete surface for one purpose.

Resources